Day: May 15, 2024

Pinnacle Bankshares Corporation Announces Quarterly Cash Dividend of 25 Cents per Share

ALTAVISTA, Va., May 15, 2024 (GLOBE NEWSWIRE) — Pinnacle Bankshares Corporation (“Pinnacle” or the “Company”) (OTCQX: PPBN), the one-bank holding company for First National Bank (the “Bank”), announced today that its Board of Directors declared a cash dividend of $0.25 per share on May 14, 2024, payable June 7, 2024, to shareholders of record as of May 24, 2024. The $0.25 per share cash dividend is equal to the $0.25 dividend paid last quarter and marks the forty-seventh consecutive quarter that a dividend has been declared. “Pinnacle is pleased to provide a cash dividend of $0.25 per share to our shareholders this quarter,” stated Aubrey H. Hall, III, President and Chief Executive Officer for both the Company and the Bank. Mr. Hall further commented, “This return on investment is consistent with our prior cash dividend, despite...

Continue reading

Genius Group Announces 2023 Financial Results, 150% Pro Forma Revenue Growth to $70.4 million

Singapore, May 15, 2024 (GLOBE NEWSWIRE) — Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading provider of AI-powered, digital-first education solutions, announced today its financial results for the year ended December 31, 2023. Business Highlights for Fiscal 2023 2023 audited revenue increased 27% to $23.1 million from $18.2 million in 2022. Pro forma 2023 revenue increased 150% to $70.4 million from $28.1 million in 2022, including revenue from the FatBrain AI transaction. Students and users increased 24% to 5.5 million from 4.4 million in 2022. Gross profit increased to $11.9 million or 52% of revenue compared to $8.6 million, or 47% of revenue in 2022. Net loss after tax reduced 90% to ($5.7) million compared to ($56.0) million in 2022. On a pro forma basis, net loss...

Continue reading

Star Equity Holdings to Release First Quarter 2024 Financial Results on May 20th

OLD GREENWICH, Conn., May 15, 2024 (GLOBE NEWSWIRE) — Star Equity Holdings, Inc. (Nasdaq: STRR; STRRP), (“Star Equity” or the “Company”), a diversified holding company, announced today that it will release its financial results for the first quarter ended March 31, 2024, before the market opens on Monday, May 20, 2024. A conference call is scheduled for 10:00 a.m. ET (7:00 a.m. PT) on May 20, 2024, to discuss the results and management’s outlook. The call may be accessed by dialing: Toll Free: 1-833-630-1956 International: 1-412-317-1837 A simultaneous webcast of the call may be accessed online from the Events & Presentations link, on the Investor Relations page of the Star Equity website at: https://www.starequity.com/events-and-presentations/presentations. An archived replay of the webcast will be available shortly after...

Continue reading

Cheetah Net Supply Chain Service Inc. Announces Closing of $8.19 Million Follow-on Public Offering

CHARLOTTE, N.C., May 15, 2024 (GLOBE NEWSWIRE) — Cheetah Net Supply Chain Service Inc. (“Cheetah Net” or the “Company”) (NASDAQ: CTNT), a supplier of parallel-import vehicles sourced in the U.S. to be sold in the PRC market and a logistics and warehouse service provider, today announced the closing of its follow-on offering of 13,210,000 shares of Class A common stock. Each share of Class A common stock was sold at an offering price of $0.62, for gross proceeds of $8.19 million, before deducting placement agent fees and other offering fees and expenses. All the shares of Class A common stock were offered by the Company. Cheetah Net intends to use the net proceeds received from the offering to fund working capital and to develop its warehousing and logistics services. AC Sunshine Securities LLC acted as the sole placement agent...

Continue reading

Nordicus Partners Corporation Acquires 95% Stake in Orocidin A/S

Beverly Hills, California., May 15, 2024 (GLOBE NEWSWIRE) — Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in providing Nordic and U.S. Life Sciences companies with optimal conditions to establish themselves on the U.S. market, announced today that it has entered into an agreement with Orocidin A/S (“Orocidin”) to acquire a 95% stake from eleven of Orocidin’s shareholders for $38,000,000. Nordicus will be issuing 38 million restricted common shares in an all-stock transaction to the selling shareholders. With Nordicus becoming Orocidin’s single largest shareholder, Henrik Rouf, CEO of Nordicus, and Henrik Keller, Director of Nordicus, will both join Orocidin’s Board of Directors. Henrik Rouf stated, “We are thrilled to become the largest shareholder of Orocidin,...

Continue reading

Fusion Fuel Green Receives Notice from Nasdaq Regarding Company’s Shareholders’ Equity

DUBLIN, Ireland, May 15, 2024 (GLOBE NEWSWIRE) — Fusion Fuel Green PLC (Nasdaq: HTOO) (“Fusion Fuel” or the “Company”), an emerging leader in the green hydrogen sector, today announced that on May 8, 2024, the Company received a deficiency notice (the “Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, since the Company’s Form 20-F for the fiscal year ended December 31, 2023 reported shareholders’ equity of $3,022,125, the Company no longer complied with Nasdaq listing rules (the “Rules”) requiring companies listed on the Nasdaq Global Market to maintain a minimum of $10,000,000 in shareholders’ equity. Under the Rules, the Company has 45 calendar days from the date of the Notice to submit a plan (the “Plan”) to regain compliance. If the Plan is accepted, Nasdaq...

Continue reading

Touax: Stable activity in 1st quarter 2024

PRESS RELEASE        Paris, 15 May 2024 – 17 h 45 YOUR OPERATIONAL LEASING SOLUTION FOR SUSTAINABLE TRANSPORTATION Stable activity in 1st quarter 2024 €36.4 million in revenues for the first three months of the year, stable compared with 1st quarter 2023 (-2%) Leasing revenue on owned equipment up +13.1% Total restated revenue for the 1st quarter 2024 amounts to €36.4 million (€36.6 million at constant currency and scope1), stable compared to €37.1 million of restated revenue at the same period in 2023. Restated Revenue from activities (*) Q1 2024   Q1 2023   Variation   (in € thousand) Leasing revenue on owned equipment 19,381 17,139 2,242 Ancillary services 3,021 5,031 -2,010 Total leasing activity 22,402 22,170 232 Sales of owned equipment 12,213 13,053 -840 Total sales of equipment 12,213 13,053 -840 Total...

Continue reading

PHAXIAM provides Business and Financial Update for the First Quarter of 2024

PHAXIAM provides Business and Financial Update for the First Quarter of 2024 Webinar (in French) today, May 15, 2024, at 6.00 pm CEST Accelerated clinical efforts to roll-out PHAXIAM’s strategy in order to create a global phage-therapy leader in high-value indications Cash and cash equivalents of €5.8 million, as of March 31, 2024 Lyon (France) and Cambridge (MA, US), May 15, 2024, at 5.45 pm CEST – PHAXIAM Therapeutics (Euronext: PHXM; FR0011471135), a biopharmaceutical company developing innovative treatments for severe and resistant bacterial infections, today provides a business and financial update for the first quarter of 2024. Thibaut du Fayet, Chief Executive Officer of PHAXIAM Therapeutics, stated: “Almost a year after the creation of PHAXIAM, the company is well on track to become a leading player in phage therapies targeting...

Continue reading

Transgene’s Combined General Meeting of May 15, 2024

Strasbourg, France, May 15, 2024, 05:45 p.m. CEST – The Combined Ordinary and Extraordinary General Meeting of Transgene’s shareholders was held today (May 15, 2024) at 10:00 a.m. at the Company’s headquarters (400 boulevard Gonthier d’Andernach – Parc d’Innovation – 67400 Illkirch-Graffenstaden, France). The meeting was chaired by Alessandro Riva, Chairman and CEO, to approve the Company’s financial statements for the year ended December 31, 2023, and to vote on the other resolutions submitted for approval. The replay of the Combined General Meeting is available via Transgene’s website and here.   The Combined General Meeting adopted all resolutions recommended by the Board of Directors. The Combined General Meeting notably has appointed one new director, Michel Baguenault de Puchesse, as non-independent director. Michel Baguenault de...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.